Skip to content

Clinical trials

Phase 2 Anemia, Refractory trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory Phase: Phase 2 Country / region: United States Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
20021
20033
20041
20056
20064
20073
20092
20101
20112
20131
20151
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated8
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center8
Roswell Park Cancer Institute4
H. Lee Moffitt Cancer Center and Research Institute3
Masonic Cancer Center, University of Minnesota3
National Cancer Institute (NCI)3
Wake Forest University Health Sciences3
Alliance for Clinical Trials in Oncology2
Case Comprehensive Cancer Center2
Memorial Sloan Kettering Cancer Center2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory53
Anemia, Refractory, with Excess of Blasts45
Myelodysplastic Syndromes45
Leukemia35
Leukemia, Myelomonocytic, Chronic31
Myeloproliferative Disorders24
Leukemia, Myeloid, Acute22
Precursor Cell Lymphoblastic Leukemia-Lymphoma22
Leukemia, Myeloid, Chronic-Phase17
Myelodysplastic-Myeloproliferative Diseases17

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.